Dejgaard TF, Frandsen CS, Kielgast U, Storling J, et al. Liraglutide enhances insulin secretion and prolongs the remission period in adults with newly diagnosed type 1 diabetes (the NewLira study): A randomized, double-blind, placebo-controlled trial. Diabetes Obes Metab 2024 Aug 27. doi: 10.1111/dom.15889.
PMID: 39192527